It contains the active drug semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps to decrease appetite and increase feelings of fullness, thereby aiding in weight loss
Because GLP-1s reduce overall food volume, people may unknowingly lose this secondary fluid source as well, on top of drinking less
Do note that this is often different from IV injections
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro) work by slowing gastric emptying and activating receptors in the brainstem, which can trigger nausea and vomiting
These innovative treatments mimic natural incretin hormones that your body should be producing but often can't in sufficient quantities when you're insulin resistant